BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33465696)

  • 21. Recent developments on (-)-colchicine derivatives: Synthesis and structure-activity relationship.
    Ghawanmeh AA; Al-Bajalan HM; Mackeen MM; Alali FQ; Chong KF
    Eur J Med Chem; 2020 Jan; 185():111788. PubMed ID: 31655432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation.
    Han HW; Lin HY; He DL; Ren Y; Sun WX; Liang L; Du MH; Li DC; Chu YC; Yang MK; Wang XM; Yang YH
    Chem Biodivers; 2018 Nov; 15(11):e1800289. PubMed ID: 30194898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects on tubulin polymerization and down-regulation of c-Myc, hTERT and VEGF genes by colchicine haloacetyl and haloaroyl derivatives.
    Marzo-Mas A; Falomir E; Murga J; Carda M; Marco JA
    Eur J Med Chem; 2018 Apr; 150():591-600. PubMed ID: 29550732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
    Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
    Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of colchicine C-ring analogues tethered with aliphatic linkers suitable for prodrug derivatisation.
    Fournier-Dit-Chabert J; Vinader V; Santos AR; Redondo-Horcajo M; Dreneau A; Basak R; Cosentino L; Marston G; Abdel-Rahman H; Loadman PM; Shnyder SD; Díaz JF; Barasoain I; Falconer RA; Pors K
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7693-6. PubMed ID: 23103097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent colchicine-site ligands with improved intrinsic solubility by replacement of the 3,4,5-trimethoxyphenyl ring with a 2-methylsulfanyl-6-methoxypyridine ring.
    Álvarez R; Aramburu L; Gajate C; Vicente-Blázquez A; Mollinedo F; Medarde M; Peláez R
    Bioorg Chem; 2020 May; 98():103755. PubMed ID: 32200330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of Schizandrin derivatives as tubulin polymerization inhibitors.
    Dileep Kumar G; Siva B; Bharathi K; Devi A; Pavan Kumar P; Anusha K; Lambhate S; Karunakar T; Kumar Tiwari A; Suresh Babu K
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127354. PubMed ID: 32631552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of novel non-racemic indole-containing allocolchicinoids.
    Shchegravina ES; Maleev AA; Ignatov SK; Gracheva IA; Stein A; Schmalz HG; Gavryushin AE; Zubareva AA; Svirshchevskaya EV; Fedorov AY
    Eur J Med Chem; 2017 Dec; 141():51-60. PubMed ID: 29028531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenyl 4-(2-oxopyrrolidin-1-yl)benzenesulfonates and phenyl 4-(2-oxopyrrolidin-1-yl)benzenesulfonamides as new antimicrotubule agents targeting the colchicine-binding site.
    Gagné-Boulet M; Bouzriba C; Chavez Alvarez AC; Fortin S
    Eur J Med Chem; 2021 Mar; 213():113136. PubMed ID: 33472119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
    Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New synthetic thiocolchicine derivatives as lowtoxic anticancer agents.
    Lee SH; Park SK; Kim JM; Kim MH; Kim KH; Chun KW; Cho KH; Youn JY; Namgoong SK
    Arch Pharm (Weinheim); 2005 Dec; 338(12):582-9. PubMed ID: 16353277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic substituted indolizines as new colchicine site tubulin polymerisation inhibitors.
    Sardaru MC; Craciun AM; Al Matarneh CM; Sandu IA; Amarandi RM; Popovici L; Ciobanu CI; Peptanariu D; Pinteala M; Mangalagiu II; Danac R
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1581-1595. PubMed ID: 32752898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tubulin inhibitors: Discovery of a new scaffold targeting extra-binding residues within the colchicine site through anchoring substituents properly adapted to their pocket by a semi-flexible linker.
    Maklad RM; AbdelHafez EMN; Abdelhamid D; Aly OM
    Bioorg Chem; 2020 Jun; 99():103767. PubMed ID: 32325332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor agents 273. Design and synthesis of N-alkyl-thiocolchicinoids as potential antitumor agents.
    Kozaka T; Nakagawa-Goto K; Shi Q; Lai CY; Hamel E; Bastow KF; Brossi A; Lee KH
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4091-4. PubMed ID: 20542428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site.
    Wang G; Peng Z; Zhang J; Qiu J; Xie Z; Gong Z
    Bioorg Chem; 2018 Aug; 78():332-340. PubMed ID: 29627654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of a novel legumain-cleavable colchicine prodrug with cell-specific toxicity.
    Smith RL; Åstrand OA; Nguyen LM; Elvestrand T; Hagelin G; Solberg R; Johansen HT; Rongved P
    Bioorg Med Chem; 2014 Jul; 22(13):3309-15. PubMed ID: 24842619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: In Vitro, in Vivo, molecular docking, molecular dynamics, and SAR studies.
    Hammouda MM; Elmaaty AA; Nafie MS; Abdel-Motaal M; Mohamed NS; Tantawy MA; Belal A; Alnajjar R; Eldehna WM; Al-Karmalawy AA
    Bioorg Chem; 2022 Oct; 127():105995. PubMed ID: 35792315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-alpha-Aminoacyl Colchicines as Promising Anticancer Agents.
    Marzo-Mas A; Conesa-Milián L; Noppen S; Liekens S; Falomir E; Murga J; Carda M; Marco JA
    Med Chem; 2021; 17(1):21-32. PubMed ID: 31793423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of long-chain homologues of colchicine with tubulin.
    Marzo-Mas A; Barbier P; Breuzard G; Allegro D; Falomir E; Murga J; Carda M; Peyrot V; Marco JA
    Eur J Med Chem; 2017 Jan; 126():526-535. PubMed ID: 27915168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.